| Sarah E Buckingham, MD | |
|
29 Hospital Plaza, Suite 602, Stamford, CT 06902-3602 | |
| (203) 276-4464 | |
| (203) 276-4468 |
| Full Name | Sarah E Buckingham |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 13 Years |
| Location | 29 Hospital Plaza, Stamford, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447549639 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 279517 (New York) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | 55337 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stamford Hospital | Stamford, CT | Hospital |
| Greenwich Hospital Association - | Greenwich, CT | Hospital |
| Norwalk Hospital | Norwalk, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stamford Health Medical Group Inc | 6901099746 | 355 |
News Archive
For a slow-growing microbe that multiplies infrequently, Mycobacterium tuberculosis, the pathogen that causes tuberculosis (TB) has long puzzled researchers as to how it develops resistance to antibiotics so quickly, in a matter of weeks to months.
Grants of almost $19 million will help to develop technologies to dramatically reduce the cost of DNA sequencing, the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, announced today.
While young men with prostate cancer have a low risk of dying early, those with advanced forms of cancer do not live as long as older men with similar forms of the disease. That is the conclusion of a new study published in the July 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
A new technique developed at Rensselaer Polytechnic Institute allows researchers to collect large amounts of biochemical information from nanoscale bone samples.
CTS Corporation today announced fourth quarter 2009 revenues of $133.9 million, 6% higher than third quarter 2009 revenues of $126.6 million. Fourth quarter 2009 net earnings were $4.1 million, or $0.12 per diluted share, including a discrete tax valuation allowance charge of $2.5 million (or $0.07 per diluted share). Excluding this charge, fourth quarter non-GAAP adjusted net earnings were $6.6 million, or $0.19 per diluted share, compared to third quarter 2009 net earnings of $4.5 million, or $0.13 per diluted share.
› Verified 9 days ago
| Entity Name | Stamford Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154633980 PECOS PAC ID: 6901099746 Enrollment ID: O20101025000743 |
News Archive
For a slow-growing microbe that multiplies infrequently, Mycobacterium tuberculosis, the pathogen that causes tuberculosis (TB) has long puzzled researchers as to how it develops resistance to antibiotics so quickly, in a matter of weeks to months.
Grants of almost $19 million will help to develop technologies to dramatically reduce the cost of DNA sequencing, the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, announced today.
While young men with prostate cancer have a low risk of dying early, those with advanced forms of cancer do not live as long as older men with similar forms of the disease. That is the conclusion of a new study published in the July 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
A new technique developed at Rensselaer Polytechnic Institute allows researchers to collect large amounts of biochemical information from nanoscale bone samples.
CTS Corporation today announced fourth quarter 2009 revenues of $133.9 million, 6% higher than third quarter 2009 revenues of $126.6 million. Fourth quarter 2009 net earnings were $4.1 million, or $0.12 per diluted share, including a discrete tax valuation allowance charge of $2.5 million (or $0.07 per diluted share). Excluding this charge, fourth quarter non-GAAP adjusted net earnings were $6.6 million, or $0.19 per diluted share, compared to third quarter 2009 net earnings of $4.5 million, or $0.13 per diluted share.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah E Buckingham, MD 29 Hospital Plaza, Suite 602, Stamford, CT 06902-3602 Ph: (203) 276-4464 | Sarah E Buckingham, MD 29 Hospital Plaza, Suite 602, Stamford, CT 06902-3602 Ph: (203) 276-4464 |
News Archive
For a slow-growing microbe that multiplies infrequently, Mycobacterium tuberculosis, the pathogen that causes tuberculosis (TB) has long puzzled researchers as to how it develops resistance to antibiotics so quickly, in a matter of weeks to months.
Grants of almost $19 million will help to develop technologies to dramatically reduce the cost of DNA sequencing, the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, announced today.
While young men with prostate cancer have a low risk of dying early, those with advanced forms of cancer do not live as long as older men with similar forms of the disease. That is the conclusion of a new study published in the July 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
A new technique developed at Rensselaer Polytechnic Institute allows researchers to collect large amounts of biochemical information from nanoscale bone samples.
CTS Corporation today announced fourth quarter 2009 revenues of $133.9 million, 6% higher than third quarter 2009 revenues of $126.6 million. Fourth quarter 2009 net earnings were $4.1 million, or $0.12 per diluted share, including a discrete tax valuation allowance charge of $2.5 million (or $0.07 per diluted share). Excluding this charge, fourth quarter non-GAAP adjusted net earnings were $6.6 million, or $0.19 per diluted share, compared to third quarter 2009 net earnings of $4.5 million, or $0.13 per diluted share.
› Verified 9 days ago
Dr. Derek Cheng, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 29 Hospital Plz Ste 602, Stamford, CT 06902 Phone: 203-276-4464 | |
Dr. Michael Kofi Adusei, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 30 Shelburne Rd, Stamford Hospital, Stamford, CT 06902 Phone: 203-276-1000 Fax: 203-276-7081 | |
Dr. Victoria Marie Knightly, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 680 E Main St # 567, Stamford, CT 06901 Phone: 475-219-6707 Fax: 956-508-9773 | |
Dr. Irwin Potkewitz, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 923 Sunset Rd, Stamford, CT 06903 Phone: 203-322-0821 Fax: 203-329-8311 | |
Dr. Ellyn Sue Shander, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1933 Long Ridge Rd, Stamford, CT 06903 Phone: 203-595-9205 Fax: 203-329-8011 | |
Dr. Elisa M Rambo, M. D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 680 E Main St # 599, Stamford, CT 06901 Phone: 480-347-2570 Fax: 480-865-2329 | |
Dr. Sarah A Mulukutla, MD, MPH Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 29 Hospital Plaza, Suite 602, Stamford, CT 06902 Phone: 203-276-4464 Fax: 203-276-4468 |